Yutao Liu from Georgia Regents University: Delaying the Progression of Glaucoma

Video

Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.

At the ARVO 2016 meeting in Seattle, WA, Yutao Liu, MD, PhD, Georgia Regents University, discussed how he and his team can potentially target genes to either reduce glaucoma or provide neuroprotection specifically for the mitochondria in the retina.

Liu concluded, "One thing I want to emphasize is eye disease is a very severe disease. Especially for glaucoma, the main thing is that in the clinic, most people are not aware of the glaucoma they have because it's a painless disease. So, we recommend people over the age of 40 to go see a clinician in opthalmology to do an eye exam to serve as the baseline, since glaucoma depends on progression."

Recent Videos
Differentiating Between Different Types of Alopecia, with Jerry Shapiro, MD
Julie Harper, MD: Discussing Acne Treatment Updates, Unmet Needs Among Patients
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD
Review of Recent Advancements in Dermatology, with Matthew Zirwas, MD
Allison Moser, MSN, RN, FNP-BC | Credit: Allison Moser on LinkedIn
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD
Lucy Mathew, NP
Lavinia Iordache, PA
© 2024 MJH Life Sciences

All rights reserved.